|
1. Fauci AS. Harrison's principles of internal medicine: McGraw-Hill Education. 2015. 2. Farhadi R, Hajiabolhassan F, Akhlaghi M, Jalaie S, Akbarian M. Vestibular evoked myogenic potentials in patients with inactive stage of systemic lupus erythematosus. Audiology. 2013;22(2):63-72. 3. Juge P-A, Lee JS, Lau J, Kawano-Dourado L, Serrano JR, Sebastiani M, et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur. Respir. J. 2021;57(2(. DOI: 10.1183/13993003.00337-2020. 4. Baghbanian M, Amirbaigy M, Salmanroghani H, Baghbanian A. Methotrexate Hepatotoxicity the Danger Not to Be Ignored. SSU_Journals. 2013;21(2):257-64. 5. Liu L, Liu S, Wang C, Guan W, Zhang Y, Hu W, et al. Folate supplementation for methotrexate therapy in patients with rheumatoid arthritis: a systematic review. JCR. 2019;25(5):197-202. DOI: 10.1097/RHU.0000000000000810. 6. Moghimi N, KhaledRahmani FS, Babahajian A, Sharifi P, Ramezani S. Assessment of hepatic fibrosis by transient elastography in rheumatoid arthritis patients receiving methotrexate. 2018. SJKU 2020, 24(6): 37-45. 7. Sadeghzadeh F, Sadeghzadeh A, Changizi-Ashtiyani S, Bakhshi S, Mashayekhi FJ, Mashayekhi M, et al. The effect of hydro-alcoholic extract of Ceratonia Silique L. on spermatogenesis index in rats treated with cyclophosphamide: An experimental study. IJRM. 2020;18(4):295. doi: 10.18502/ijrm.v13i4.6892. 8. Alimoradian A, Changizi-Ashtiyani S, Farahani AG, Kheder L, Rajabi R, Sharifi A. Protective effects of pomegranate juice on nephrotoxicity induced by captopril and gentamicin in rats. IJKD. 2017;11(6):422-429. 9. Iranikhah A, Shapouri J, Heidari A, Aghaali M, Hajian H. Effects of silymarin on nonalcoholic fatty liver disease in children: A crossover clinical trial. J Maz Univ Med. 2017;26(144):119-26. URL: http://jmums.mazums.ac.ir/article-1-9244-en.html. 10. Moosavifar N, Mohammadpour A, Jallali M, Karimi G, Saberi H. Evaluation of effect of silymarin on granulosa cell apoptosis and follicular development in patients undergoing in vitro fertilization. East. Mediterr. Health J. 2010; 16 (6), 642-645. 11. Xiong F, Guan Y-S. Cautiously using natural medicine to treat liver problems. WJG. 2017;23(19):3388. doi: 10.3748/wjg.v23.i19.3388. 12. Palasciano G, Portincasa P, Palmieri V, Ciani D, Vendemiale G, Altomare E. The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs. CTR. 1994;55(5):537-45. 14. Zhang W, Hong R, Tian T. Silymarin's protective effects and possible mechanisms on alcoholic fatty liver for rats. Biomol Ther. 2013;21(4):264. doi: 10.4062/biomolther.2013.020. 15. Ezhilarasan D. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. AJG. 2018;19(2):56-6 . 17. Yaman T, Uyar A, Kaya MS, Keles ÖF, Uslu BA, Yener Z. Protective effects of silymarin on methotrexate-induced damages in rat testes. Braz. J Pharm Sci. 2018;54. 18. GholizadeNikpey M, Mojtahedin A, Seyedsharifi R. Pain-relieving effects of Silymarin and its interaction with histamine H1 receptors in Rats. J Fasa Univ Med Sci. 2017;7(2):265-74. DOI: 20.1001.1.22285105.2017.7.2.15.6. 19. Fallah Huseini H, Larijani B, Raajabipour B, Heshmat R. The effect of Silymarin on glycemic control of type II diabetes: A double blind randomized clinical trial. J Med Plant Res. 2005;4(13):13-7. DOI: 20.1001.1.2717204.2005.4.13.3.4. 20. Shavandi M, Moini A, Shakiba Y, Mashkorinia A, Dehghani M, Asar S, et al. Silymarin (Livergol®) decreases disease activity score in patients with rheumatoid arthritis: A non-randomized single-Arm clinical trial. IJAAI. 2017:99-106. 21. Johnson TM, Register KA, Schmidt CM, O'Dell JR, Mikuls TR, Michaud K, et al. Correlation of the Multi‐Biomarker disease activity score with rheumatoid arthritis disease activity measures: a systematic review and Meta‐Analysis. AC&R. 2019;71(11):1459-72. 23. Pincus T, Castrejon I, Block J. FRI0678 Validity of three 0-10 visual analog scales (VAS) for quantitative physician assessment of inflammation, damage, and distress to supplement a physician global assessment 0-10 vas. BMJ Publishing Group Ltd; 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.5588. 24. Shirani F, Soltany-Bajestani F. Comparing new diagnostic criteria of 2010 ACR/EULAR with 1987 ACR criteria in rheumatoid arthritis. Tehran Univ. Med. J. 2017;74(10):706-14. URL: http://tumj.tums.ac.ir/article-1-7834-en.html. 25. Nordberg LB, Lillegraven S, Aga A-B, Sexton J, Olsen IC, Lie E, et al. Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. RMD open. 2018;4(2):e000752. http://dx.doi.org/10.1136/rmdopen-2018-000752. 26. Mehrzadi S, Fatemi I, Esmaeilizadeh M, Ghaznavi H, Kalantar H, Goudarzi M. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats. Biomed Pharmacother 2018;97:233-9. 28. Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Jt Bone Spine. 2019;86(3):301-7. 30. Jamali B, Jamali S, Shokri Kalehsar N. Effect of vitamin C on liver injury after taking methotrexate in rats. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch. 2018;28(1):44-9. DOI: 10.29252/iau.28.1.44. 31. Vardi N, Parlakpinar H, Ozturk F, Ates B, Gul M, Cetin A, et al. Potent protective effect of apricot and β-carotene on methotrexate-induced intestinal oxidative damage in rats. FCT. 2008;46(9):3015-22. 33. Fallah Huseini H, Hemati A, Alavian S. A review of herbal medicine: Silybum marianum. J Med Plant Res. 2004;3(11):14-24. DOI: 20.1001.1.2717204.2004.3.12.9.1. 34. Mukhtar S, Xiaoxiong Z, Qamer S, Saad M, Mubarik MS, Mahmoud AH, et al. Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats. Saudi J Biol Sci. 2021;28(1):717-23. 36. Ali N, Rashid S, Nafees S, Hasan SK, Sultana S. Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem. 2014;385(1):215-23. 38. Ali N, Rashid S, Nafees S, Hasan SK, Shahid A, Majed F, et al. Protective effect of Chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: An experimental approach. Chem Biol Interact. 2017;272:80-91. 40. de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, de Oliveira LPM. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. WJG. 2017;23(27):5004. doi: 10.3748/wjg.v23.i27.5004. 41. Mirnezami M, Jafarimanesh H, Rezagholizamenjany M, Alimoradian A, Ranjbaran M. The effect of silymarin on liver enzymes in patients taking isotretinoin: A randomized clinical trial. Dermatol Ther. 2020;33(2):e13236. 43. Jamalian M, Mahmodiyeh B, Saveiee S, Solhi H. Investigating the impact of silymarin on liver oxidative injury. Fam Med Prim. Care Rev. 2020;9(3):1707. doi: 10.4103/jfmpc.jfmpc_929_19. 44. Kalopitas G, Antza C, Doundoulakis I, Siargkas A, Kouroumalis E, Germanidis G, et al. The impact of Silymarin in patients with Non-Alcoholic Fatty Liver Disease: a systematic review and meta-analysis: Silymarin in NAFLD: A systematic review. Nutrition. 2020:111092. 46. Safian Isfahani Y, Aslani A, Memarzadeh MR. Preventive effect of novel nanomissile of silymarin on liver injury induced by carbon tetrachloride in rat. SJKUMS. 2021;26(2):1-11. DOI: 10.52547/sjku.26.2.1. 47. Heidari B, Siahkouhian M, Vakili J, ZARGHAMI KA. The effect of a short term hydro-alcoholic extract of milk theistle(silymarin) supplementation on aerobic exercise induced changes of the liver enzymes levels in active men. Cmja. 2015; 1258-1270. 48. Khokhar A, Qayyum A, Khokhar M. Hepatotoxicity; protective effect of silymarin against methotrexate induced in mice. Professional Med J. 2017;24(8):1200-5. 50. Hussain SA, Mortada AH, Jasim NA, Gorial FI. Silibinin improves the effects of methotrexate in patients with active rheumatoid arthritis: pilot clinical study. Oman Med. J. 2016;31(4):263. doi: 10.5001/omj.2016.52. 51. Alimoradian A, Ansarihadipour H, Changizi-Ashtiyani S, Chehrei A, Talebi R, Davudian S, et al. Protective effects of omega-3, atorvastatin, vitamin E and vitamin C against doxorubicin-induced cardiotoxicity in rats: a comparison study. Physiol Pharmacol. 2018;22(1):63-72. URL: http://ppj.phypha.ir/article-1-1336-en.html 52. Bhattacharya S. Phytotherapeutic properties of milk thistle seeds: An overview. J Adv Pharm Educ Res. 2011;1:69-79. 53. Camini FC, Costa DC. Silymarin: not just another antioxidant. JBCPP. 2020;31(4).
|
